All India Institute of Medical Sciences, New Delhi is a public hospital and medical research university based in New Delhi, India. The institute is governed by the AIIMS Act, 1956 and operates autonomously under the Ministry of Health and Family Welfare.

During the past decade, All India Institute of Medical Sciences conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 34 clinical trials were completed, i.e. on average, 29.1% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 23 clinical trials were completed. i.e. 44.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "All India Institute of Medical Sciences" #1 sponsor was "All India Institute of Medical Sciences, New Delhi" with 87 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Gilead Sciences" with 7 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored and "Shire" with 6 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "All India Institute of Medical Sciences" #1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 14 trials as a collaborator, "Indian Council of Medical Research" with 6 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "Council of Scientific and Industrial Research, India" with 3 trials as a collaborator and "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include 155 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "All India Institute of Medical Sciences" are "Tuberculosis" (9 trials), "Crohn's Disease" (7 trials), "COVID-19" (5 trials), "Atopic Dermatitis" (4 trials) and "Cachexia" (3 trials). Many other conditions were trialed in "All India Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "All India Institute of Medical Sciences" are "Drug" (131 trials), "Other" (30 trials), "Device" (20 trials), "Procedure" (20 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Filgotinib" (5 trials), "placebo" (4 trials), "Baricitinib" (3 trials) and "Galcanezumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "All India Institute of Medical Sciences" are 207 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 57 active trials in "All India Institute of Medical Sciences". 3 are not yet recruiting, 31 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 112 completed trials in All India Institute of Medical Sciences, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in All India Institute of Medical Sciences, 9 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 55 trials that are defined as “Not Applicable".

All India Institute of Medical Sciences has several departments that took part in Clinical trials: "Institute Rotary Cancer Hospital, All India Institute of Medical Sciences" - 6 trials, "Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences" - 4 trials, "Department of Surgical Disciplines, All India Institute of Medical Sciences" - 2 trials